NL-OMON33795尚未招募不适用
Effect of fluticasone proprionate 0.05% cream on narrow band UV-B phototherapy in active vitiligo: a randomised single blinded controlled trial - UVBVIT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with active vitiligo, eligible for NB-UVB phototherapy;
- •Subjects attending the outpatient department of the SNIP;
- •Adult patients: * 18 years;
- •Subject is willing and able to give written informed consent.
排除标准
- •With a personal or a family history of skin cancer (non-melanoma skin cancer: first degree family members, melanoma: any family member)
- •With a personal history of photosensitivity and/or phototoxicity disorders
- •With skin type I (according to Fitzpatrick classification I-VI)
- •Who are pregnant
- •Who are taking medications known to cause photosensitivity and/or phototoxicity and chronic or very frequent use of any medication that can influence the UVB response (eg. tetracycline, retinoids, sulfonamids, psoralens, NSAID*s)
- •With other skin diseases that would impair evaluation of repigmentation, such as psoriasis and eczema.
- •Who are not able to have 2 times weekly NB-UVB phototherapy
- •With local immunosuppressive treatment or 6 weeks prior to enrolment. For these patients a washout period of 6 weeks will be required.
研究者
相似试验
进行中（未招募）
1 期
Efficacy of Fluticasone Propionate associated With Salmeterol underwent allogeneic hematopoietic stem cell transplantatioBronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT)..EUCTR2020-003010-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)243
已完成
1 期
Effects of fluticasone nasal spray on clinical symptoms and serum IgENasal polypIRCT20140519017756N40Mashhad University of Medical Sciences34
进行中（未招募）
1 期
Clinical assessment of fluticasone propionate/ salmeterol xinafoate HFA MDI in 6-month to 4-year-old Japanese patients with bronchial asthmaMedDRA version: 19.0Level: LLTClassification code 10003555Term: Asthma bronchialSystem Organ Class: 100000004855bronchial asthmaEUCTR2016-003479-22-Outside-EU/EEAGlaxoSmithKline Research and development Ltd370
已完成
不适用
ebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy studyACTRN12615000096550Safa Baris100
已完成
不适用
Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimeRespiratory disease requiring bronchoscopyJPRN-UMIN000017645Gifu Municipal Hospital20